StockPriceToday
Netflix Inc (NFLX)
About Netflix Inc
Netflix Inc. operates as a streaming entertainment service provider, offering television series, documentaries, and feature films across various genres and languages to members in over 190 countries. The company's pioneering role in streaming entertainment has made NFLX stock price highly sensitive to subscriber growth and competitive dynamics.
Netflix revolutionized content consumption by offering on-demand streaming services that allow viewers to watch content anytime, anywhere, on internet-connected devices. The company's investment in original content production has created popular series and films that differentiate its platform from competitors.
The company's global expansion strategy has enabled it to reach diverse audiences worldwide while spreading content costs across a larger subscriber base. Netflix's data-driven approach to content creation and recommendation algorithms help optimize viewer engagement and retention, factors that significantly influence NFLX stock price movements.
Netflix faces increasing competition from traditional media companies launching their own streaming services, including Disney+, HBO Max, and Apple TV+. The company's ability to maintain subscriber growth while managing content costs and pricing strategies remains critical to its long-term success and market valuation.
NFLX Stock 12 Month Chart
Latest News for NFLX
Netflix Inc. (NFLX) is preparing to lay off about 5% of its global workforce as early as next week, according to a report by media newsletter Puck.
Netflix remains a dominant global streaming platform with double-digit revenue growth and expanding margins. Learn more about NFLX stock here.
Netflix NFLX shares have plunged 26.8% year to date, underperforming the Zacks Broadcast Radio and Television industry’s decline of 9.3% and the Zacks Consumer Discretionary sector’s return of 25.8%.
Other Popular Stocks
Rallybio Corporation (RLYB) is a clinical-stage biotechnology company developing life-transforming therapies for patients with severe and rare diseases, focusing on areas with significant unmet...
Cerence Inc. (CRNC) is a leading provider of AI-powered conversational assistants and connected car services for the global automotive industry.
Xilio Therapeutics Inc. (XLO) is a clinical-stage biopharmaceutical company developing tumor-selective immunotherapies designed to maximize anti-tumor activity while minimizing systemic toxicity for cancer patients.